PRTS_ARX

Gene
ARX
Disease
PRTS
Inheritance
XR
Classification
Definitive
Total Score
12
Publications Reviewed
2
Publication Span
4.75 years
Last Updated
08/18/2025
Curator(s)
Laurel Hiatt, Macayla Weiner

Description

Partington syndrome (PRTS) is an X-linked ARX-related neurodevelopmental disorder associated with coding polyalanine tract expansions, particularly the recurrent pA2 24-bp duplication c.441_464dup (also reported historically as c.429_452dup) that expands the second polyalanine tract from 12 to 20 alanines. Reported phenotypes include intellectual disability with dystonic hand movements/dysarthria, with overlap across the ARX polyalanine expansion spectrum.

Genetic evidence

Total: 12

Singular EvidenceProbandsPMID:205062066Review of published ARX polyalanine expansion cases reported the recurrent pA2 24-bp duplication (c.429_452dup; now c.441_464dup) in 38 families, including 6 families with Partington syndrome.
Collective EvidenceAllelePMID:205062061Locus-specific pA2 expansion data support a length/structure effect: the 12-to-20 alanine pA2 expansion is associated with PRTS in a subset of families, while longer uninterrupted pA2 expansion was associated with more severe infantile spasms and a glycine-interrupted expansion with milder PRTS.
StatisticsCase-control dataPMID:260297076Cohort-level testing of 138 individuals with intellectual disability identified pathogenic pA2 c.441_464dup in 8 patients from 6 families; retrospective evaluation of affected males with dup24 identified hand dystonia consistent with Partington-like syndrome.
3 rows

Experimental evidence

Total: 0

No experimental evidence details available.

Note: Maximum score caps apply at evidence type, category, and supercategory levels, so section totals may be lower than the raw sum of row scores.